Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04046562 · ClinicalTrials.gov registry record · NA

Pain and Weight Treatment: Development and Trial of PAW

A NA study of Pain, Chronic and Obesity, Adolescent, sponsored by Connecticut Children's Medical Center.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04046562: Recruiting NA study of Pain, Chronic and Obesity, Adolescent, sponsored by Connecticut Children's Medical Center.

NCT04046562 is a NA study of Pain, Chronic and Obesity, Adolescent that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 50 participants, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04046562, a NA study of Pain, Chronic and Obesity, Adolescent, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Pediatric weight management efficacy is impacted by failure to complete treatment protocols and, for those that do complete treatment, a return to unhealthy behaviors. This project tests whether treating pain, a common comorbid condition to pediatric obesity, will enhance treatment. This study will generate results that can be translated into immediate improvements in care for families seeking treatment for pediatric obesity.

Primary Outcome

The number of sessions of fit5 attended will be compared between the group attending PAW and those in the information control group.

Interventions

  • BEHAVIORAL PAW
  • BEHAVIORAL Pain Education

Study Locations (1)

Connecticut

  • Connecticut Children's Medical Center - Hartford

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-08-14
Est. Completion 2026-05
Phase NA

What NCT04046562 shows while recruiting

NCT04046562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 2 interventions - of which PAW is the first listed.

NCT04046562 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT04046562 about?

NCT04046562 is a clinical study titled "Pain and Weight Treatment: Development and Trial of PAW". Pediatric weight management efficacy is impacted by failure to complete treatment protocols and, for those that do complete treatment, a return to unhealthy behaviors. This project tests whether treating pain, a common comorbid condition to pediatric obesity, will enhance treatment. This study will ...

What is the current status of trial NCT04046562?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-08-14. Estimated completion is 2026-05.

What conditions does trial NCT04046562 study?

This clinical trial studies the following conditions: Pain, Chronic, Obesity, Adolescent, CBT.

What interventions are being tested in trial NCT04046562?

The interventions under investigation include: PAW (BEHAVIORAL), Pain Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT04046562?

This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04046562 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04046562's enrollment target sits among peer trials

50 35th of 48 higher than 14 of 48 other Pain, Chronic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04046562, the US trial registry maintained by the National Library of Medicine. NCT04046562 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.